Skip to main content
TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
2.900
-0.010 (-0.34%)
Nov 20, 2024, 4:00 PM EST - Market closed

TELA Bio Revenue

TELA Bio had revenue of $18.96M in the quarter ending September 30, 2024, with 25.94% growth. This brings the company's revenue in the last twelve months to $68.65M, up 29.34% year-over-year. In the year 2023, TELA Bio had annual revenue of $58.45M with 41.13% growth.

Revenue (ttm)
$68.65M
Revenue Growth
+29.34%
P/S Ratio
1.04
Revenue / Employee
$302,419
Employees
227
Market Cap
114.23M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202358.45M17.04M41.13%
Dec 31, 202241.42M11.96M40.58%
Dec 31, 202129.46M11.25M61.77%
Dec 31, 202018.21M2.77M17.91%
Dec 31, 201915.45M7.17M86.68%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
American Well 254.04M
Akoya Biosciences 86.82M
Journey Medical 57.77M
Cidara Therapeutics 44.65M
Cibus 4.15M
Century Therapeutics 2.68M
Revenue Rankings

TELA News

More News